Rationale: Repair of damaged endothelium is important in recovery from acute lung injury. In animal models, bone marrow-derived endothelial progenitor cells differentiate into mature endothelium and assist in repairing damaged vasculature.
Introduction
The acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) are devastating causes of respiratory failure characterized by disruption of the alveolarcapillary membrane resulting in accumulation of proteinaceous pulmonary edema fluid and coincident hypoxemia. Patients with ALI/ARDS usually require mechanical ventilatory support, have a prolonged length of stay in an intensive care setting, and continue to have an unacceptably high mortality ranging between 30 to 50%. Despite recent advances in therapeutic ventilatory strategies for ARDS patients, efforts to identify circulating factors that predict survival in these critically ill patients have been unrevealing [1] . Additionally, a full explanation of the mechanisms responsible for repairing the injured alveolar-capillary membrane in patients with this disorder remains elusive.
Stem cells have been identified in adult humans that are capable of maintaining, generating, and replacing terminally differentiated cells during normal physiologic turnover, and in response to acute tissue damage [2, 3] . Bone marrow-derived stem cells can differentiate into a variety of tissue-specific, human cell types [4] [5] [6] [7] . In a murine model, alveolar and bronchial epithelial cells derived from bone marrow donors have been identified after stem cell transplant in lethally irradiated recipients [8] . In humans, after allogeneic hematopoietic stem cell transplantation, pulmonary endothelial and epithelial cells have been observed in the lungs of recipients that are of donor origin [9] .
Endothelial progenitor cells (EPCs) are a specific subtype of hematopoietic stem cell that has been isolated from the peripheral blood of humans [10] [11] [12] . EPCs migrate from the bone marrow to the peripheral circulation where they contribute to the repair of injured endothelium and to the formation of new blood vessels [10, 13] . Hill and colleagues have reported that levels of circulating EPCs may be a prognostic biological marker for vascular function and cumulative cardiovascular risk in male subjects without a history of cardiovascular disease [14] . However, circulating EPCs have not previously been identified in critically ill patients.
Damage to the pulmonary vascular endothelium occurs in patients with ARDS [15] . EPCs may provide a circulating pool of cells that could form a cellular "patch" at the site of denuding injury, or could serve as a reservoir to replace damaged endothelium [14] . It is unknown at present if circulating progenitor cells are associated with enhanced repair of damaged lung, including the pulmonary endothelium, in patients with acute lung injury. We hypothesized that EPCs are present at increased levels in the circulation of patients with acute lung injury, and that measurement of the number of circulating EPCs may serve as a prognostic biomarker for patients with ALI/ARDS. Some of the results of this study have been previously reported in the form of an abstract [16] .
Methods (497 words)
Additional detail on the methods is provided in an online supplement.
Patient characteristics
Patients on mechanical ventilation, with and without ALI, were screened from three Emory University-affiliated medical ICUs. Patients were enrolled consecutively over a 2 year time period (2002) (2003) (2004) . All ALI patients enrolled met the AmericanEuropean Consensus Committee criteria [17] , and had an at-risk diagnosis for this disorder. Patients requiring mechanical ventilation without ALI or an underlying risk factor for ALI were categorized as control patients (hereafter referred to as "ICU controls"). Patients who had undergone a surgical procedure requiring general endotracheal anesthesia, those who were admitted for trauma, and those with acute coronary syndrome were excluded. Additionally, healthy individuals were recruited from the general population (hereafter referred to as "healthy controls"). These individuals had no significant medical history and were on no medications. Informed consent was obtained from either the subjects themselves or from designated surrogates prior to enrollment in the study. Our study was approved by the Institutional Review Board at Emory University.
Endothelial progenitor cell colony isolation
Peripheral blood was obtained from all ALI patients within 72 hours of their meeting criteria for this disorder, within 72 hours of intubation in ICU control patients, and from healthy controls. The buffy coat was isolated using density-gradient centrifugation, and recovered cells were processed similar to previously described methods [14] . Briefly, cells recovered after centrifugation were washed, then suspended in growth medium. All these cells were plated on fibronectin-coated dishes and incubated for 24 hours. Cells not adherent to the plate after 24 hours (i.e. in the supernatant) were collected by gentle aspiration and counted for each subject's sample. Thereafter, they were re-plated onto new fibronectin-coated plates at a concentration of Patients with ALI who remained in the ICU on a ventilator had a second blood specimen obtained on day seven that was processed identically.
Analysis
Statistics were performed using JMP software (SAS Institute, Inc., Cary, NC).
Not normally distributed data are reported as median and 25-75% quartiles; nonparametric analyses were performed on this data. The time from the development of ALI to death was compared between patients with low and high colony counts using a log rank test. Multivariable logistic regression analysis was performed on patients with ALI with EPC number as the primary exposure variable of interest [18] . Reported p values are two sided, and an alpha value of 0.05 was used in all analyses.
Results

Demographics of ALI patients and ICU controls
Forty-five patients with ALI and ten ICU control patients were enrolled in the protocol ( after the initial pre-plating step that were actually plated for the final CFU assessment was similar between the two groups (p=0.16). Seven healthy volunteers without any comorbid diagnoses were also enrolled with a mean age of 32 ± 2 years.
The risk factor for ALI was secondary to direct lung injury, predominantly pneumonia, in 33 of the 45 ALI patients. Septic shock was present in 44% of the ALI patients. The overall mortality rate for the ALI patients was 42%. Comparing the survivors to the non-survivors of ALI, both groups had direct lung injury as a predisposing factor for the development of ALI, with pulmonary infections predominating (table 2). The incidence of sepsis and septic shock defined using established criteria [19] was also not statistically different between survivors and nonsurvivors. The survivor and non-survivor subgroups were similar in terms of age, gender, alcohol and tobacco use, and the number of cells available after the initial pre-plating step that were actually plated for the final CFU assessment was similar between the two groups (p=0.61). Survivors had lower initial APACHE II and SOFA scores, and a small but significantly higher peripheral white blood cell count (p<0.01).
The overall mortality rate for the ICU controls was 20%. These patients had a variety of underlying diagnoses and the majority was ventilated for airway protection (table 3) .
Morphology of progenitor cell colonies
A photomicrograph of a typical EPC CFU on the fibronectin-coated plate from a patient with ALI is illustrated in figure 1a , and a representative ICU control patient's CFU is illustrated in figure 1b . Morphologically, the CFUs from our patients and controls (both ICU and healthy) appeared similar to those obtained by us and other investigators utilizing these isolation methods [14, 20] . In a subset of 13 consecutive 
EPC colony numbers in entire cohort of ALI patients and ICU controls
The absolute numbers of CFUs per well present in the patients with ALI, in the ICU controls, and in ambulatory controls are illustrated in figure 3. The ALI patients had a significantly higher number of CFUs than the healthy controls (p<0.05), but the median number of CFUs was not statistically different between the ALI patients and ICU controls (p=0.95). The number of CFUs in the healthy controls was similar to previously reported values for healthy individuals in the literature utilizing this method of isolating EPCs [20] .
Relationship of EPC colony numbers to demographic factors and survival
In the subset of patients with ALI there was a significant survival advantage in the ALI patients with a higher number of EPC CFUs per well (p<0.04) (figure 4). control patients who survived and those who expired, although the number of these patients was small (n=10).
EPC colony numbers over time in ALI patients
From our initial cohort of twenty-six patients, seventeen patients with ALI were consented to a second blood draw seven days after the initial specimen. Blood was not obtained in 9 of these 26 ALI patients as 6 had expired, 2 were no longer ventilated, and one refused a subsequent blood draw. In this subgroup of patients, there were no significant changes in the EPC CFUs over time (figure 6). At seven days after the initial sampling, the ALI survivors (n=12) had a higher median number of EPC CFUs (115 with CI 25-75% of 34-150) compared to ALI non-survivors (n=5) (55 with CI 25-75% of 22-151) although this was not statistically significant. The additional 19 ALI patients enrolled were not consented for subsequent blood sampling given the stability of the EPC CFU numbers over time in the initial ALI cohort.
Discussion
In this study, we demonstrated that EPCs are mobilized in the circulation of patients with ALI and ARDS, disorders characterized by severe pulmonary endothelial injury. Overall, the number of circulating EPCs in ALI patients is approximately twofold higher than in healthy control subjects. More importantly, an increased number of circulating EPCs was associated with improved survival, even after correcting for differences in age, gender, and severity of illness. In those ALI patients with blood specimens obtained over a 7-day period, the number of circulating EPCs did not significantly change. Thus, the measurement of EPC CFUs is promising as a novel prognostic marker for survival in patients with ALI. These findings also support the possibility that adequate mobilization of EPCs from the bone marrow in ALI could potentially contribute to repair and recovery of damaged pulmonary endothelium.
Recent studies in mice lend credence to the idea that marrow-derived stem cells can serve as progenitor cells for the tissues of various solid organs [21] . Studies in the lung have focused mainly on the regeneration of pulmonary epithelium. After transplanting a single marrow stem cell into recipient mice that had been marrow-ablated, Krause and colleagues demonstrated engrafted donor cells with alveolar type II cell and airway epithelial cell phenotypes [8] . Engraftment in the lungs of these animals was the highest of any organ studied. In a study by Kotton and colleagues, plastic-adherent lacZ+ marrow cells were injected into mice without marrow ablation, and apparent engraftment of cells bearing type I pneumocyte morphology were observed that was particularly marked after pre-treatment with intratracheal bleomycin [22] . Furthermore, mesenchymal stem cells are able to engraft in the lung after bleomycin injury. These cells originated from the bone marrow, and after engraftment exhibited an epithelial morphology [23] . Recently, the derivation of type I alveolar cells, lung fibroblasts, and interstitial monocytes/macrophages from circulating progenitor cells has been reported in a parabiotic mouse model, most robustly in conjunction with irradiation and elastase exposure [24] . A common conclusion of all these studies is that the presence of acute lung injury in the transplant recipients (either from radiation or via chemical agents)
facilitates engraftment and presumably the stem cell-dependent repair process.
Less has been reported regarding repair of damaged pulmonary endothelium, although pulmonary endothelial damage is characteristic of a variety of conditions, including ALI [15] . The utility of circulating EPCs as a treatment for damaged vasculature has been reported in ischemic vascular disease [25] and for the treatment of ischemic retinopathy [26] . A similar type of therapy for damaged pulmonary endothelium appears possible. Transplanted hematopoietic stem cells home to the pulmonary vasculature, as reported by Suratt and colleagues [9] . These investigators examined lung biopsy specimens from a group of female patients who had undergone cord blood transplantation from male donors. A modest rate of epithelial chimerism (2.5-8.0%) was observed in the recipients' lungs in addition to a more marked rate of endothelial chimerism (37.5-42.3%), promoting the idea that adult human progenitor cells could play a potentially therapeutic role in lung repair. Moreover, the utility of EPCs may not be limited to these cells merely replacing the injured vascular endothelium. For example, EPCs have been reported to serve as a potential source for angiogenic factors [27] . They may secrete paracrine growth factors that regulate the angiogenic response and may participate in cell-cell contact events that facilitate endothelial cell sprouting and growth.
EPCs may be useful for disease risk stratification and prognosis, as illustrated by Hill and colleagues where patients with lower numbers of circulating EPCs had a higher
Framingham risk score, signifying a greater risk for cardiac events [14] . These investigators were also able to demonstrate a relationship between subjects' endothelial function (as measured by brachial reactivity) and the number of circulating EPCs.
Circulating EPCs in our patients with ALI presumably originate from the bone marrow, suggesting novel therapeutic interventions to increase the numbers of these progenitor cells. Mobilization of hematopoietic stem cells from the bone marrow to the periphery has been induced clinically or experimentally through the use of cytokines, chemokines, and chemotherapeutic agents and this has potential therapeutic implications for enhancing lung repair in ALI. The most commonly employed strategy in humans to mobilize stem cells is the use of granulocyte colony stimulating factor (GCSF) or granulocyte-monocyte colony stimulating factor (GMCSF), usually in conjunction with disease-specific chemotherapeutic agents [28] . Importantly, GMCSF has been demonstrated to improve gas exchange in a small series of patients with severe sepsis and respiratory dysfunction [29] . However, the role of GMCSF in the treatment of ALI remains to be determined.
A majority of the ALI patients in this study were septic. Recent investigations have examined lethally irradiated C57Bl/6 mice that have been reconstituted with bone marrow derived from green fluorescent protein-transgenic mice. The mice were exposed to either intranasal lipopolysaccharide (LPS, found in the bacterial capsule of gram negative organisms) or to intranasal saline. A significantly increased number of circulating EPCs was present in the circulation of the LPS-exposed animals compared to the saline-treated [30] . An elevation in the circulating number of mature endothelial cells (ECs) has been reported in patients with sepsis, a major risk factor for the development of ALI, indicative of heightened endothelial cell activation [31] . These works highlight potential mechanisms involving inflammatory mediators in endothelial damage and repair. We did not measure the level of ECs in our patient population and a relationship between EPCs and ECs remains to be evaluated.
The number of EPC CFUs in our ALI patients correlated positively with male gender. In animal models, estrogens have been reported to have anti-apoptotic effects on progenitor cells [32] . Given that the median ages of our ALI patients was in the perimenopausal range, the women in the cohort would be expected to have lower estrogen levels than a younger cohort of patients. Lower estrogen concentrations in this subgroup of women with ALI may have been operative in lowering the values of EPC CFUs in these patients compared to men. The number of men in the ALI survivor and nonsurvivor groups was similar, however.
Our study is not without potential limitations. EPCs were identified in these patients' circulation utilizing methods that have been previously described and validated by us and others [14, 20] . EPC CFU numbers in our healthy control patients were similar to that reported previously [20] . Nevertheless, some degree of contamination by nonEPCs is possible. To minimize this problem, the initial pre-plating of the peripheral blood mononuclear cells was performed in order to avoid isolating mature circulating endothelial cells. Additionally, we utilized markers of endothelial lineage to further clarify the type of cells growing in culture. Although these methods are widely accepted, they are still not perfectly accurate as few markers and stains are specific for a cell type, and results may vary depending on the immaturity or senescence of the cell [33] . Factors such as timing of the blood sampling in relationship to the onset of lung injury did not have an immediate impact on the colony number, as counts remained stable over a week in patients with ALI. Finally, this study did not utilize other functional assays previously performed with EPCs to assess migration and proliferation. However, we believe that the cell culturing technique we employed in our assay incorporates a measure of not only the number of circulating EPCs, but also the ability of these EPCs to form endothelioid colonies, thus encompassing both the migratory and proliferative capacity of this progenitor cell population.
The observation that our ICU controls had similarly elevated EPCs was intriguing but not completely unexpected. These patients were critically ill on mechanical ventilation, although their severity of illness was less than in ALI subjects. It is unknown
at this time what an appropriate ICU control patient should be, although this group of controls met no criteria for acute lung injury, and had no risk factors for its development.
The group of ICU controls was small (n=10), and had a preponderance of neurologic diagnoses, including cerebrovascular events that may have resulted in elevations in circulating EPCs [34] . Further investigation in a larger number of non-ALI control subjects is necessary to demonstrate the prognostic significance of EPC number in critically ill patients with other diagnoses.
In summary, the measurement of circulating EPCs appears to have prognostic implications for ALI, a disorder characterized by severe endothelial damage. Pulmonary and critical care investigators have expressed interest in the role of stem cells to help repair the damaged lung in ALI, with the understanding that mechanisms of stem cell release, targeting, proliferation, and differentiation in lung tissue must be established [30] . Defining the role of endothelial progenitor cells in repair of the acutely injured lung will provide a rationale for novel approaches to therapy, but the utility of stem cell therapy as a clinical modality requires additional basic and clinical research. 
ALI Survivors, n=26
ALI Non-survivors, n=19
EPC CFUs Days after the Development of ALI To ensure the specificity of our techniques, as a negative control, cultured human smooth muscle cells were stained similarly; these cells stained positively with lectin but did not take up DiLDL. As positive controls, cultured human endothelial cells were utilized that stained doubly positive with lectin and DiLDL.
Patients with ALI who remained in the ICU on a ventilator had a second blood specimen obtained on day seven that was processed identically.
Analysis
Not normally distributed data are reported as median and 25-75% quartiles; nonparametric analyses were performed on this data. The time from the development of ARDS to death was compared between patients with low and high colony counts using a log-rank test. Multivariable logistic regression analysis was performed on patients with ALI with EPC number as the primary exposure variable of interest. Effects of the following independent variables were also evaluated: sequential organ failure (SOFA) score, age, and gender. A backward elimination modeling strategy was used [E3] .
Individual interaction terms between EPC colony numbers and each individual confounding variable were entered into the initial model to assess for effect modification; no interaction terms were significant (p value > .05). Reported p values are two sided, and an alpha value of 0.05 was used in all analyses. We assumed that an equal proportion of patients would have high and low EPC CFU numbers. With an alpha of 0.05, a power of 0.8, a mortality of 70% in the high EPC group, and a mortality of 30% in the low EPC group, we estimated that it would be necessary to enroll 24 patients using a chi-squared analysis.
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